S3E9 - Marty Allain, JD | Post-Scrip: The ASPL Pharmacy Law Podcast
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
S3E9 - Marty Allain, JD | Post-Scrip: The ASPL Pharmacy Law Podcast
-
Narrated by:
-
By:
About this listen
In this episode of Post-Scrip, Henry introduces Marty Allain, JD. They discuss the upcoming "How Drug Manufacturer Restrictions and Recent Court Decisions are Re-Shaping 340B Drug Distribution and Delivery Models".
Pharmaceutical manufacturers continue to restrict the delivery of 340B drug discounts to contract pharmacies in response to the growth of 340B sales, perceived non-compliance with 340B program requirements, and statutory interpretation. These restrictions have a significant financial impact on hospitals, health centers, and other health care providers that participate as “covered entities” in the 340B program.
This presentation will also cover other “hot topics” with respect to 340B contract pharmacy arrangements, including the impact of the U.S. District Court Decision, Genesis vs. Becerra, rejecting a restrictive interpretation of “patient” under the 340B program.
Join us at the 35th annual conference: Developments in Pharmacy Law Seminar , November 7-10, 2024 in Phoenix, Arizona